Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
89pct
52d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · fourth_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021. H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act. H.R. 5546/S. 2974, the PROTECT Act. H.R. 8202, the Preventing Vape Use Act.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $620,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021. H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act. H.R. 5546/S. 2974, the PROTECT Act.
Client expense: Not reported · Firm income: $36,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021. H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act. H.R. 5546/S. 2974, the PROTECT Act. H.R. 8202, the Preventing Vape Use Act.
Client expense: $610,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021. H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act. H.R. 5546/S. 2974, the PROTECT Act.
Client expense: Not reported · Firm income: $36,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021. H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act. H.R. 5546/S. 2974, the PROTECT Act.
Client expense: $620,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021. H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act. H.R. 5546/S. 2974, the PROTECT Act.
Client expense: Not reported · Firm income: $36,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Tobacco
Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021 H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act H.R. 5546/S. 2974, the PROTECT Act H.R. 6286, the Clarifying Authority over Nicotine Act of 2021
Client expense: $630,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE